0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Pharmacogenetics/Pharmacogenomics

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Original Investigation  | 
Naltrexone vs Placebo for the Treatment of Alcohol Dependence:  A Randomized Clinical Trial
David W. Oslin, MD; Shirley H. Leong, PhD; Kevin G. Lynch, PhD; et al.
JAMA Internal Medicine
Invited Commentary  | 
A Call for Accurate Pharmacogenetic Labeling:  Telling It Like It Is
Wylie Burke, MD, PhD; Kenneth Thummel, PhD
JAMA Internal Medicine
Original Investigation  | 
Clinical Evidence Supporting Pharmacogenomic Biomarker Testing Provided in US Food and Drug Administration Drug Labels
Bo Wang, PharmD; William J. Canestaro, MSc; Niteesh K. Choudhry, MD, PhD
JAMA Neurology
Editorial  | 
Human Neurons Derived From Induced Pluripotent Stem Cells as a New Platform for Preclinical Drug Screening and Development
Fan Liao, PhD; David M. Holtzman, MD